Search results
These sections contain recommendations for managing children with COVID-19 or multisystem inflammatory syndrome in children (MIS-C). Clinical Management of Children Summary Overview of guidance on managing hospitalized and nonhospitalized children with COVID-19 or MIS-C
- Clinical Management of Children Summary
Clinical judgment is needed when applying recommendations...
- Introduction to Critical Care
Introduction to Critical Care Management of Children With...
- Clinical Management of Children Summary
Apr 11, 2020 · The most common adverse events were nausea/vomiting, diarrhea, abdominal pain, lack of appetite, itching and bloating. Treatment of COVID-19 in ambulatory persons with lopinavir/ritonavir rather than placebo may increase the risk of serious adverse events (RR: 1.58; 95% CI: 0.79, 3.16; moderate CoE).
Mar 18, 2024 · The most common symptoms of COVID-19 in children are fever and cough, but many children can experience sore throat, rhinorrhea, headache, fatigue, shortness of breath, or gastrointestinal symptoms, including nausea, vomiting, or diarrhea 9, 10, 11, 12.
Sep 1, 2020 · Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, disproportionally affects adults (children <5% in most reports).1 Adult critical illness is characterized by acute hypoxemia, multiorgan failure, and high mortality.2,3 Reported risk factors for severe illness include age, cardiorespiratory comorbidities, obesity, and laboratory findings ...
May 6, 2020 · The existing COVID-19 clinical practice guidelines for public health policies have mostly focused on the prevention, diagnosis and treatment in adults, with little attention paid to children. Few of them are based on evidence from systematic reviews ( 14 ).
